Zuletzt aktualisiert: 18. Mai 2026
Chronic prostatitis or chronic inflammation of the prostate gland is considered a difficult-to-treat issue in the urology office. This topic will give you a whole picture of chronic prostatitis treatment. This condition is divided into 2 categories by its natural history, with entirely different management spectrums. The following recommendation is based on scientific data referenced from US literature published in 2000.
- Urologiezentrum Bangkok Krankenhaus Thailand Online buchen 02-310-3009 bhquro@bdms.co.th
- Krankenhaus Samitivej Sriracha Chonburi 088-022-1445

Empfehlung zur Behandlung der chronischen Prostatitis
- Bakteriell bedingte Prostatitis
- Antibiotika
- Ciprofloxacin – 75% cure rate with up to 259 days of treatment
- Amoxicillin-clavulanate – 6-week alternative for suspected ciprofloxacin-resistant pathogen
- Trimethoprim-sulfamethoxazole (TMP-SMX) – 67% cure rate with up to 140 days of treatment
- Alpha blockers (Terazosin or Alfuzosin) – when used in combination with antibiotics, clinical studies show significantly higher improvement rates and lower recurrence rates
- Antibiotika

- Nonbacterial-caused prostatitis (Chronic Pelvic Pain Syndrome)
- Alpha blockers (Terazosin or Alfuzosin) – clinical studies show significantly higher improvement rates and lower recurrence rates
There is not a lot of high-level evidence-based treatment options in chronic prostatitis management. This condition requires proper individualized treatment designation based on the patient’s complaint and symptoms, because the main objective in chronic prostatitis treatment is to improve the patient’s quality of life.

If you have any questions, please discuss with your trusted urologist, or you are welcome to contact me directly.
Sie können meine offizielle Homepage besuchen hier.
Frequently Asked Questions About Chronic Prostatitis Treatment
What is the difference between bacterial and nonbacterial chronic prostatitis?
Bacterial chronic prostatitis (Category II) is caused by a confirmed bacterial infection of the prostate gland and is treated with long-term antibiotics. Nonbacterial chronic prostatitis (Category III, also called Chronic Pelvic Pain Syndrome or CPPS) has no identifiable bacterial cause and accounts for the majority of chronic prostatitis cases. The two types require different treatment strategies — antibiotics are central to bacterial prostatitis, while alpha blockers are the primary pharmacological option for CPPS.
What antibiotics are used for chronic bacterial prostatitis and how long is treatment?
The evidence-based antibiotic options are Ciprofloxacin (75% cure rate, up to 259 days of treatment), Trimethoprim-sulfamethoxazole (67% cure rate, up to 140 days), and Amoxicillin-clavulanate as a 6-week alternative for suspected Ciprofloxacin-resistant pathogens. Adding an alpha blocker (Terazosin or Alfuzosin) to antibiotics significantly improves cure rates and reduces recurrence compared to antibiotics alone.
What is the treatment for nonbacterial chronic prostatitis?
For nonbacterial chronic prostatitis (CPPS), alpha blockers such as Terazosin or Alfuzosin are the most scientifically supported pharmacological treatment. They relax the smooth muscle of the prostate and bladder neck, reducing voiding symptoms and pelvic pain. Because CPPS has many overlapping symptom domains, treatment is always individualized — the primary goal is improving quality of life rather than achieving a biochemical cure.
If you are experiencing chronic pelvic pain, urinary symptoms, or symptoms suggesting chronic prostatitis, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. Beratungstermin buchen.
**Haftungsausschluss:** Dieser Inhalt wurde von Dr. Soarawee Weerasopone, einem Facharzt für Urologie am Bangkok Hospital Headquarters, verfasst und überprüft. Er dient ausschließlich Bildungszwecken und stellt keine medizinische Beratung dar. Konsultieren Sie immer einen qualifizierten Mediziner, bevor Sie eine medizinische Behandlung beginnen.
Medizinisch verfasst & überprüft von: Dr. Soarawee Weerasopone (Dr. Pom) – Fachärztin für Urologie, Bangkok Hospital Hauptverwaltung. International Stipendiatin: Baylor College of Medicine (USA) · Juntendo University (Japan) · Chang Gung Memorial Hospital (Taiwan).

Dr. Soarawee Weerasopone (Dr. Pom) ist ein Facharzt für Urologie am Bangkok Hospital Headquarters, spezialisiert auf Männergesundheit, Roboterchirurgie (Da Vinci System) und Nierensteinbehandlung. Er hat internationale Fortbildungen am Baylor College of Medicine (USA), am Juntendo University Hospital (Japan) und am Chang Gung Memorial Hospital (Taiwan) absolviert. Alle medizinischen Inhalte auf dieser Website werden von Dr. Soarawee auf der Grundlage seiner klinischen Erfahrung und seiner internationalen Ausbildung verfasst und überprüft.

